Ara
Toplam kayıt 2, listelenen: 1-2
Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders
(Springer International Publishing Ag, 2017)
Accumulating evidence suggests that sigma-1 receptors play a role in the pathophysiology of neuropsychiatric diseases, as well as in the mechanisms of some selective serotonin reuptake inhibitors (SSRIs). Among the SSRIs, ...
Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases
(Korean Neuropsychiatric Assoc, 2013)
Fluvoxamine is a selective serotonin reuptake inhibitor that is approved for psychiatric disorders such as major depressive episodes and obsessive-compulsive disorder. Beside inhibition of serotonin reuptake, fluvoxamine ...